Dr. Brian Mandell and Dr. Naomi Schlesinger discuss recent published evidence related to gout, as well as study results presented at the American College of Rheumatology Convergence 2020 virtual annual meeting. Dr. Schlesinger begins with an introduction on a recent published systematic review indicating that the manifestations of gout extend beyond the joints, affecting other organs and tissues. Dr. Schlesinger also provides an overview of some of the challenges encountered in clinical practice with the use of urate-lowering therapy. Dr. Schlesinger focuses on two abstracts concerning gout-related comorbidities, particularly cardiovascular disease. Dr. Mandell focus on two abstracts related to the safety and use of urate-lowering therapy, specifically allopurinol, febuxostat, and pegloticase. Dr. Mandell also discuss 2 abstracts related to the systemic nature of gout; one abstract focuses on heart failure, while the other focuses on the lumbar spine.
Course Credit:
1.00 AMA PRA Category 1 CreditTM
Dates:
Opens: 2021-01-22
Closes: 2022-01-22
Target Audience:
This activity was developed for rheumatologist, nephrologists, and other healthcare professionals involved in the care of patients with gout.
This activity is supported by an independent educational grant from Horizon Therapeutics.
-
Brian Mandell, MD, PhD
Professor of Medicine
Chairman of Academic Medicine
Cleveland Clinic
Cleveland, OH -
Naomi Schlesinger, MD
Professor of Medicine Chief, Division of Rheumatology
Rutgers-Robert Wood Johnson Medical School
New Brunswick, New Jersey
Downloads
Learning Objectives
- Summarize the latest evidence related to combination pharmacologic treatment of patients with gout who do not achieve the target serum urate level with monotherapy
- Summarize the latest evidence related to complications associated with gout
- Incorporate evidence-based research into clinical practice
Faculty Disclosures
Brian Mandell, MD, PhD
Consultant: Horizon
Data Monitoring Safety Board: Horizon
Speakers Bureau: Genentech
Naomi Schlesinger, MD
Advisory Board: IFM, Johnson and Johnson
Research Support: Amgen, Pfizer
Speakers Bureau: Horizon
Accreditation and Certification
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Additional Content Planners
Eugene Cullen, MD (Peer Reviewer)No significant relationship to disclose
Gregory Scott, PharmD, RPh (Medical Writer)
No significant relationships to disclose.
Annenberg Center for Health Sciences
All members of the Eisenhower Health Education Committee have no relevant commercial relationships to disclose.